Last reviewed · How we verify

rE-4 Freeze-dried Powder

CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Phase 1 active Small molecule

rE-4 Freeze-dried Powder is a Small molecule drug developed by CSPC ZhongQi Pharmaceutical Technology Co., Ltd.. It is currently in Phase 1 development. Also known as: Recombinant Exendin-4 Freeze-dried Powder.

At a glance

Generic namerE-4 Freeze-dried Powder
Also known asRecombinant Exendin-4 Freeze-dried Powder
SponsorCSPC ZhongQi Pharmaceutical Technology Co., Ltd.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about rE-4 Freeze-dried Powder

What is rE-4 Freeze-dried Powder?

rE-4 Freeze-dried Powder is a Small molecule drug developed by CSPC ZhongQi Pharmaceutical Technology Co., Ltd..

Who makes rE-4 Freeze-dried Powder?

rE-4 Freeze-dried Powder is developed by CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (see full CSPC ZhongQi Pharmaceutical Technology Co., Ltd. pipeline at /company/cspc-zhongqi-pharmaceutical-technology-co-ltd).

Is rE-4 Freeze-dried Powder also known as anything else?

rE-4 Freeze-dried Powder is also known as Recombinant Exendin-4 Freeze-dried Powder.

What development phase is rE-4 Freeze-dried Powder in?

rE-4 Freeze-dried Powder is in Phase 1.

Related